Stereotactic radiotherapy of the prostate: fractionation and utilization in the United States
Joseph P. Weiner, David Schwartz, Meng Shao, Virginia Osborn, Kwang Choi, David Schreiber
Radiat Oncol J. 2017;35(2):137-143.   Published online 2017 Jun 30     DOI: https://doi.org/10.3857/roj.2017.02026
Citations to this article as recorded by Crossref logo
Stereotactic body radiation therapy (SBRT) for high-risk prostate cancer: Where are we now?
Alejandro Gonzalez-Motta, Mack Roach
Practical Radiation Oncology.2018; 8(3): 185.     CrossRef
Utilization of Stereotactic Radiosurgery for Renal Cell Carcinoma Brain Metastases
Waqar Haque, Vivek Verma, E.Brian Butler, Bin S. Teh
Clinical Genitourinary Cancer.2018; 16(4): e935.     CrossRef
Optimal collimator rotation based on the outline of multiple brain targets in VMAT
Jung-in Kim, Beom Seok Ahn, Chang Heon Choi, Jong Min Park, So-Yeon Park
Radiation Oncology.2018;[Epub]     CrossRef
Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes
Donald B. Fuller, Aaron D. Falchook, Tami Crabtree, Brent L. Kane, Clinton A. Medbery, Kelly Underhill, James R. Gray, Anuj Peddada, Ronald C. Chen
European Urology Oncology.2018; 1(6): 540.     CrossRef